Columbia Asset Management Astrazeneca PLC Transaction History

Columbia Asset Management

$4.01 Billion
Q1 2025

A detailed history of Columbia Asset Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Columbia Asset Management holds 8,485 shares of AZN stock, worth $589,283. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,485

Previous 8,485 -0.0%

Holding current value

$589,283

Previous $555,000 12.25%

% of portfolio

0.02%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$76.67 - $87.62 $16,024 - $18,312	-209 Reduced 2.4%	8,485 $661,000
Q2 2024 Aug 05, 2024	SELL	$66.81 - $80.83 $26,724 - $32,332	-400 Reduced 4.4%	8,694 $678,000
Q4 2023 Feb 09, 2024	SELL	$61.89 - $69.28 $25,189 - $28,196	-407 Reduced 4.28%	9,094 $612,000
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $13,423 - $14,841	-207 Reduced 2.13%	9,501 $643,000
Q3 2022 Nov 03, 2022	BUY	$53.02 - $135.75 $10,020 - $25,656	189 Added 1.99%	9,708 $532,000
Q2 2022 Aug 26, 2022	SELL	$59.26 - $71.14 $89,601 - $107,563	-1,512 Reduced 13.71%	9,519 $629,000
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $14,855 - $17,553	-275 Reduced 2.43%	11,031 $643,000
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $11,167 - $12,218	-201 Reduced 1.75%	11,306 $679,000
Q2 2021 Aug 02, 2021	SELL	$48.42 - $60.18 $9,441 - $11,735	-195 Reduced 1.67%	11,507 $689,000
Q1 2021 May 28, 2021	SELL	$47.16 - $54.44 $8,064 - $9,309	-171 Reduced 1.44%	11,702 $582,000
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $9,287 - $10,692	175 Added 1.5%	11,873 $651,000
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $2,887 - $3,705	-67 Reduced 0.57%	11,698 $619,000
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $29,722 - $35,322	-700 Reduced 5.62%	11,765 $5.87 Million
Q2 2019 Aug 15, 2019	SELL	$37.28 - $41.68 $31,688 - $35,428	-850 Reduced 6.38%	12,465 $515,000
Q1 2019 May 20, 2019	SELL	$35.49 - $43.02 $25,410 - $30,802	-716 Reduced 5.1%	13,315 $538,000
Q4 2018 Feb 12, 2019	SELL	$36.86 - $41.49 $135,902 - $152,973	-3,687 Reduced 20.81%	14,031 $533,000
Q3 2018 Nov 06, 2018	BUY	$34.76 - $39.72 $14,390 - $16,444	414 Added 2.39%	17,718 $701,000
Q4 2017 Feb 05, 2018	SELL	$32.09 - $34.78 $12,836 - $13,912	-400 Reduced 2.26%	17,304 $600,000
Q3 2017 Nov 07, 2017	BUY	$28.96 - $34.0 $512,707 - $601,936	17,704	17,704 $600,000

Others Institutions Holding AZN

# of Institutions

1,426

Shares Held

504M

Call Options Held

10M

Put Options Held

3.14M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $215B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Columbia Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Columbia Asset Management with notifications on news.

Account

Columbia Asset Management Astrazeneca PLC Transaction History